International alliance and AGREE-ment of 71 clinical practice guidelines on the management of critical care patients with COVID-19: a living systematic review

被引：21

作者：

Amer, Yasser S. ^{[1
,2
,3
,4
,33
]}

Titi, Maher A. ^{[3
,5
,33
]}

Godah, Mohammad W. ^{[6
]}

Wahabi, Hayfaa A. ^{[3
,7
]}

Hneiny, Layal ^{[8
]}

Abouelkheir, Manal Mohamed ^{[9
,35
]}

Hamad, Muddathir H. ^{[10
,33
]}

ElGohary, Ghada Metwally ^{[11
,12
,34
]}

Ben Hamouda, Mohamed ^{[13
,36
]}

Ouertatani, Hella ^{[14
,36
]}

Velasquez-Salazar, Pamela ^{[15
,37
]}

Acosta-Reyes, Jorge ^{[16
,38
]}

Alhabib, Samia M. ^{[17
,18
,39
]}

Esmaeil, Samia Ahmed ^{[3
,34
]}

Fedorowicz, Zbys ^{[19
,40
]}

Zhang, Ailing ^{[20
]}

Chen, Zhe ^{[20
]}

Liptrott, Sarah Jayne ^{[21
]}

Frungillo, Niccolo ^{[22
]}

Jamal, Amr A. ^{[3
,7
,34
]}

Almustanyir, Sami A. ^{[23
,41
]}

Dieyi, Newman Ugochukwu ^{[24
,42
]}

Powell, John ^{[25
,26
,43
]}

Hon, Katrina J. ^{[24
,27
,44
]}

Alzeidan, Rasmieh ^{[28
,34
]}

Azzo, Majduldeen ^{[29
,45
]}

Zambrano-Rico, Sara ^{[30
,46
]}

Ramirez-Jaramillo, Paulina ^{[30
,46
]}

Florez, Ivan D. ^{[31
,32
,47
]}

机构：

[1] King Saud Univ Med City, Pediat Dept, Riyadh, Saudi Arabia

[2] King Saud Univ Med City, Qual Management Dept, Clin Practice Guidelines Unit, Riyadh, Saudi Arabia

[3] King Saud Univ, Deanship Sci Res, Res Chair Evidence Based Hlth Care & Knowledge Tr, Riyadh, Saudi Arabia

[4] Alexandria Univ, Alexandria Univ Med Council, Alexandria Ctr Evidence Based Clin Practice Guide, Alexandria, Egypt

[5] King Saud Univ Med City, Patient Safety Unit, Qual Management Dept, Riyadh, Saudi Arabia

[6] Amer Univ Beirut, Fac Hlth Sci, Beirut, Lebanon

[7] King Saud Univ, Coll Med, Family & Community Med Dept, Riyadh, Saudi Arabia

[8] Amer Univ Beirut, Univ Lib, Saab Med Lib, Beirut, Lebanon

[9] Misr Int Univ, Coll Pharm, Dept Clin Pharm, Cairo, Egypt

[10] King Saud Univ, King Saud Univ Med City, King Khalid Univ Hosp, Pediat Dept,Div Neurol, Riyadh, Saudi Arabia

[11] Ain Shams Univ, Fac Med, Internal Med & Clin Hematol, Cairo, Egypt

[12] King Saud Univ, Univ Med City, Univ Oncol Ctr, Riyadh, Saudi Arabia

[13] INEAS Instance Natl Evaluat & Accreditat Sante, Clin Practice Guidelines Unit, 7 Rue Ahmed Rami le Belvedere, Tunis 1001, Tunisia

[14] Natl Author Assessment & Accreditat Healthcare IN, Clin Pathways Unit, Tunis, Tunisia

[15] Univ Antioquia, Fac Med, Unidad Evidencia & Deliberac Toma Decis UNED, Medellin, Colombia

[16] Univ Norte, Dept Publ Hlth, Barranquilla, Colombia

[17] Saudi Hlth Council, Natl Ctr Evidence Based Hlth Practice, Riyadh, Saudi Arabia

[18] King Abdullah Bin Abdulaziz Univ Hosp, Riyadh, Saudi Arabia

[19] Veritas Hlth Sci Consultancy Ltd, Huntingdon, England

[20] Zhengzhou Univ, Affiliated Hosp 1, 1 Jianshe & Rd,Erqi 15 Dist, Zhengzhou, Henan, Peoples R China

[21] Ente Osped Cantonale, Via Gallino 12, CH-6500 Bellinzona, Switzerland

[22] ASST Fatebenefratelli Sacco, Oncol Unit, PO Fateberefratelli,Piazza Principessa Clotilde 3, I-20121 Milan, Italy

[23] Minist Hlth, Riyadh, Saudi Arabia

[24] Mem Univ, Div Community Hlth & Humanities, St John, NL, Canada

[25] Natl Inst Hlth & Care Excellence, London, England

[26] Radcliffe Observ Quarter, Nuffield Dept Primary Care Hlth Sci, Radcliffe Primary Care Bldg,Woodstock Rd, Oxford OX2 6GG, England

[27] Harvard Univ, Neurosci Mind Brain & Behav, Cambridge, MA 02138 USA

[28] King Saud Univ, Coll Med, Cardiac Sci Dept, Riyadh, Saudi Arabia

[29] Int Med Ctr, Pediat Emergency Dept, Hail St, Jeddah 21451, Saudi Arabia

[30] CES Univ, Medellin, Colombia

[31] Univ Antioquia, Dept Pediat, Medellin, Colombia

[32] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada

[33] King Saud Univ, King Saud Univ Med City, King Khalid Univ Hosp, POB 7805, Riyadh 11472, Saudi Arabia

[34] 3145 King Saud Univ, Coll Med, Internal Mail 34, Riyadh 123726855, Saudi Arabia

[35] Misr Int Univ, Coll Pharm, KM 28 Cairo,Ismailia Rd, Cairo 25, Egypt

[36] INEAS 1 Instance Natl Evaluat & Accreditat Sante, 7 Rue Ahmed Rami le Belvedere, Tunis 1001, Tunisia

[37] Univ Antioquia, Fac Med, Cra 5D 62-29, Medellin, Antioquia, Colombia

[38] Univ Norte, Hlth Sci Div, Km 5 Via Puerto Colombia, Barranquilla, Colombia

[39] King Khalid Int Airport, 8006 Airport Rd, Riyadh 134453434, Saudi Arabia

[40] 3 Acre, Huntingdon PE28 4DF, Cambs, England

[41] 2448 Zarga Alyamamah St, Riyadh 11176, Saudi Arabia

[42] Canada 300 Prince Philip Dr, St John, NL A1B 3V6, Canada

[43] Natl Inst Hlth & Care Excellence NICE, 2nd Floor,2 Redman Pl, London E20 1JQ, England

[44] Harvard Mind Brain Behav Interfac Initiat, William James Hall 1380-1384,33 Kirkland St, Cambridge, MA 02138 USA

[45] Int Med Ctr, Hail St, Jeddah 21451, Saudi Arabia

[46] Calle 10A 22-04, Medellin 4440555, Antioquia, Colombia

[47] Segundo Piso Hosp Infantil San Vicente Fdn, Calle 67 53-108, Medellin 050001, Colombia

来源：

JOURNAL OF CLINICAL EPIDEMIOLOGY | 2022年 / 142卷

关键词：

guidelines; COVID-19; rapid guidelines; quality; AGREE II tool; intensive care; ACUTE ISCHEMIC-STROKE; CONSENSUS STATEMENT; ANESTHETIC MANAGEMENT; EUROPEAN-SOCIETY; RECOMMENDATIONS; ANESTHESIOLOGY; NEUROSCIENCE; CHILDREN; COLLEGE; SUPPORT;

D O I：

10.1016/j.jclinepi.2021.11.010

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Objective: We aimed to systematically identify and critically assess the clinical practice guidelines (CPGs) for the management of critically ill patients with COVID-19 with the AGREE II instrument. Study design and setting: We searched Medline, CINAHL, EMBASE, CNKI, CBM, WanFang, and grey literature from November 2019 - November 2020. We did not apply language restrictions. One reviewer independently screened the retrieved titles and abstracts, and a second reviewer confirmed the decisions. Full texts were assessed independently and in duplicate. Disagreements were resolved by consensus. We included any guideline that provided recommendations on the management of critically ill patients with COVID-19. Data extraction was performed independently and in duplicate by two reviewers. We descriptively summarized CPGs characteristics. We assessed the quality with the AGREE II instrument and we summarized relevant therapeutic interventions. Results: We retrieved 3,907 records and 71 CPGs were included. Means (Standard Deviations) of the scores for the 6 domains of the AGREE II instrument were 65%(SD19.56%), 39%(SD19.64%), 27%(SD19.48%), 70%(SD15.74%), 26%(SD18.49%), 42%(SD34.91) for the scope and purpose, stakeholder involvement, rigor of development, clarity of presentation, applicability, editorial independence domains, respectively. Most of the CPGs showed a low overall quality (less than 40%). Conclusion: Future CPGs for COVID-19 need to rely, for their development, on standard evidence-based methods and tools. (C) 2021 Elsevier Inc. All rights reserved.

引用

页码：333 / 370

页数：38

共 102 条

[1]

Alhazzani W., 2020, SAUDI CRIT CARE J, V4, P27, DOI [DOI 10.4103/SCCJ.SCCJ_15_20, 10.4103/sccj.sccj_15_20]

[2]

Alhazzani W, 2020, INTENS CARE MED, V46, P854, DOI [10.1097/CCM.0000000000004363, 10.1007/s00134-020-06022-5]

[3]

Amer YS, PROSPERO 2020 CRD420

[4]

Andrejak C, 2020, REV MAL RESPIR

[5]

[Anonymous], 2020, GUIA CUIDADO CRITICO

[6]

[Anonymous], 2020, Guidance: paediatric multisystem inflammatory syndrome temporally associated with COVID-19

[7]

[Anonymous], 2020, COVID 19 GUIDA CLINI

[8]

[Anonymous], DOCUMENTO CONGIUNTO, V1st

[9]

[Anonymous], 2020, RACCOMANDAZIONI PRAT

[10]

[Anonymous], 2020, VADEMECUM CURA PERSO

← 1 2 3 4 5 6 7 8 9 10 →